Hap Trading, LLC Intra Cellular Therapies, Inc. Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$64.37 - $75.65 $4.38 Million - $5.15 Million	68,011 New	68,011 $4.71 Billion
Q3 2021 Nov 10, 2021	SELL	$28.72 - $42.49 $136,908 - $202,549	-4,767 Reduced 24.79%	14,460 $539,000
Q2 2020 Aug 10, 2020	BUY	$14.35 - $26.64 $275,907 - $512,207	19,227 New	19,227 $494,000
Q4 2017 Feb 09, 2018	SELL	$14.27 - $16.79 $213,564 - $251,279	-14,966 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$10.77 - $22.1 $161,183 - $330,748	14,966	14,966 $236,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.